PEGFILGRASTIM-APGF

PEGFILGRASTIM-APGF was reported 198 times

These side effects are most commonly reported by patients taking PEGFILGRASTIM-APGF:

# Side effect Count
0 DEATH 23
1 OFF LABEL USE 17
2 PYREXIA 15
3 DRUG DOSE OMISSION BY DEVICE 12
4 DEVICE LEAKAGE 11
5 NAUSEA 11
6 FATIGUE 10
7 ASTHENIA 9
8 DIARRHOEA 7
9 NEUTROPENIA 7
10 DEVICE ISSUE 6
11 DEVICE OPERATIONAL ISSUE 6
12 HOSPITALISATION 6
13 DECREASED APPETITE 5
14 DYSPEPSIA 5
15 ILLNESS 5
16 NEEDLE ISSUE 5
17 NEOPLASM MALIGNANT 5
18 WHITE BLOOD CELL COUNT DECREASED 5
19 ABDOMINAL PAIN 4
20 ACCIDENTAL EXPOSURE TO PRODUCT 4
21 ANAEMIA 4
22 FEBRILE NEUTROPENIA 4
23 MALAISE 4
24 PALPITATIONS 4
25 PRURITUS 4
26 RASH 4
27 SOMNOLENCE 4
28 BONE PAIN 3
29 COUGH 3
30 DEVICE BREAKAGE 3
31 DEVICE DEFECTIVE 3
32 DIZZINESS 3
33 DRUG INEFFECTIVE 3
34 DYSGEUSIA 3
35 DYSPNOEA 3
36 EXPOSURE VIA SKIN CONTACT 3
37 FULL BLOOD COUNT ABNORMAL 3
38 FULL BLOOD COUNT DECREASED 3
39 HAEMOGLOBIN DECREASED 3
40 HEADACHE 3
41 HEART RATE INCREASED 3
42 HYPERHIDROSIS 3
43 HYPOTENSION 3
44 INFECTION 3
45 NEUROPATHY PERIPHERAL 3
46 PANCREATITIS ACUTE 3
47 PNEUMONIA 3
48 WEIGHT DECREASED 3
49 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3
50 AGITATION 2
51 ALOPECIA 2
52 ANAL HAEMORRHAGE 2
53 BACK PAIN 2
54 BLOOD DISORDER 2
55 COGNITIVE DISORDER 2
56 COLITIS 2
57 COLON CANCER STAGE IV 2
58 CONSTIPATION 2
59 DEHYDRATION 2
60 DEVICE DEPLOYMENT ISSUE 2
61 DEVICE SAFETY FEATURE ISSUE 2
62 DEVICE USE ERROR 2
63 DISCOMFORT 2
64 DRY MOUTH 2
65 DRY SKIN 2
66 EPISTAXIS 2
67 FEELING ABNORMAL 2
68 FLUSHING 2
69 GENERAL PHYSICAL HEALTH DETERIORATION 2
70 HEAD DISCOMFORT 2
71 HYPERSENSITIVITY 2
72 HYPERSENSITIVITY PNEUMONITIS 2
73 HYPOXIA 2
74 IMMUNOSUPPRESSION 2
75 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
76 INFLUENZA 2
77 INJURY ASSOCIATED WITH DEVICE 2
78 LOCALISED INFECTION 2
79 MYOSITIS 2
80 NAIL DISCOLOURATION 2
81 NAIL DISORDER 2
82 NEUTROPHIL COUNT INCREASED 2
83 NO ADVERSE EVENT 2
84 OEDEMA PERIPHERAL 2
85 PAIN 2
86 PAIN IN EXTREMITY 2
87 PLATELET COUNT DECREASED 2
88 POLYNEUROPATHY 2
89 TACHYCARDIA 2
90 VOMITING 2
91 ABDOMINAL DISTENSION 1
92 ABDOMINAL PAIN UPPER 1
93 ABDOMINAL RIGIDITY 1
94 ACCIDENTAL EXPOSURE TO PRODUCT PACKAGING 1
95 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 1
96 ADENOCARCINOMA GASTRIC 1
97 ADVERSE EVENT 1
98 AGEUSIA 1
99 AGRANULOCYTOSIS 1
100 ANAL INCONTINENCE 1
101 ANGIOEDEMA 1
102 APHONIA 1
103 ARTHRALGIA 1
104 ATYPICAL PNEUMONIA 1
105 B-CELL LYMPHOMA 1
106 BLADDER CATHETERISATION 1
107 BLINDNESS 1
108 BLOOD PRESSURE INCREASED 1
109 BLOOD THYROID STIMULATING HORMONE DECREASED 1
110 BONE CANCER 1
111 BRAIN FOG 1
112 BRAIN NEOPLASM 1
113 BREAST CANCER 1
114 BREAST CANCER FEMALE 1
115 BREAST CANCER METASTATIC 1
116 CANCER PAIN 1
117 CELLULITIS 1
118 CEREBROVASCULAR ACCIDENT 1
119 CHEMOTHERAPY 1
120 CHEST DISCOMFORT 1
121 CHEST PAIN 1
122 CHOLELITHIASIS 1
123 COLITIS ULCERATIVE 1
124 CONCUSSION 1
125 COVID-19 1
126 CRYING 1
127 CYSTITIS 1
128 CYTOKINE RELEASE SYNDROME 1
129 DEEP VEIN THROMBOSIS 1
130 DENTAL RESTORATION FAILURE 1
131 DEVICE CONNECTION ISSUE 1
132 DEVICE DELIVERY SYSTEM ISSUE 1
133 DEVICE MALFUNCTION 1
134 DEVICE MECHANICAL ISSUE 1
135 DEVICE OCCLUSION 1
136 DEVICE PHYSICAL PROPERTY ISSUE 1
137 DEVICE RELATED INFECTION 1
138 DEVICE USE ISSUE 1
139 DIFFUSE LARGE B-CELL LYMPHOMA 1
140 DISEASE RECURRENCE 1
141 DRUG HYPERSENSITIVITY 1
142 DRUG LEVEL DECREASED 1
143 DYSPHONIA 1
144 DYSPNOEA EXERTIONAL 1
145 DYSSTASIA 1
146 EATING DISORDER 1
147 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1
148 ELECTROLYTE IMBALANCE 1
149 ENDOCRINE DISORDER 1
150 ERYTHEMA 1
151 EYE DISORDER 1
152 FALL 1
153 FEEDING DISORDER 1
154 FEMALE GENITAL TRACT FISTULA 1
155 FOOD INTERACTION 1
156 FRUSTRATION TOLERANCE DECREASED 1
157 GAIT DISTURBANCE 1
158 GAIT INABILITY 1
159 GASTROINTESTINAL DISORDER 1
160 GASTROINTESTINAL TUBE INSERTION 1
161 HAEMATOCHEZIA 1
162 HEAD INJURY 1
163 HOSPICE CARE 1
164 HOT FLUSH 1
165 HYPERCALCAEMIA OF MALIGNANCY 1
166 HYPERTENSION 1
167 HYPOPHAGIA 1
168 ILEOSTOMY 1
169 IMMUNE SYSTEM DISORDER 1
170 INCORRECT DOSE ADMINISTERED BY DEVICE 1
171 INJECTION RELATED REACTION 1
172 INTENTIONAL DOSE OMISSION 1
173 INTENTIONAL PRODUCT USE ISSUE 1
174 LABORATORY TEST ABNORMAL 1
175 LEG AMPUTATION 1
176 LEUKAEMIA RECURRENT 1
177 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
178 LOWER GASTROINTESTINAL HAEMORRHAGE 1
179 LYMPHOMA 1
180 MALIGNANT NEOPLASM PROGRESSION 1
181 MALIGNANT NIPPLE NEOPLASM 1
182 MALNUTRITION 1
183 MEMORY IMPAIRMENT 1
184 MENTAL IMPAIRMENT 1
185 METASTASES TO LYMPH NODES 1
186 MIGRAINE 1
187 MOVEMENT DISORDER 1
188 MYOCARDIAL INFARCTION 1
189 NECROSIS ISCHAEMIC 1
190 NEOPLASM PROGRESSION 1
191 NERVOUSNESS 1
192 NEUTROPHIL COUNT DECREASED 1
193 OBSTRUCTIVE AIRWAYS DISORDER 1
194 OCCUPATIONAL EXPOSURE TO PRODUCT 1
195 PALMAR ERYTHEMA 1
196 PERIORBITAL INFLAMMATION 1
197 PLEURAL EFFUSION 1
198 POOR QUALITY DEVICE USED 1
199 PRODUCT PACKAGING ISSUE 1
200 PRODUCT PHYSICAL ISSUE 1
201 PRODUCT PRESCRIBING ERROR 1
202 PRODUCT USE IN UNAPPROVED INDICATION 1
203 PSYCHIATRIC SYMPTOM 1
204 PSYCHOLOGICAL TRAUMA 1
205 QUALITY OF LIFE DECREASED 1
206 RECTAL HAEMORRHAGE 1
207 RECURRENT CANCER 1
208 SCHNITZLER^S SYNDROME 1
209 SENSATION OF FOREIGN BODY 1
210 SKIN BURNING SENSATION 1
211 SKIN DISCOLOURATION 1
212 SKIN REACTION 1
213 SLEEP DISORDER 1
214 STAPHYLOCOCCAL INFECTION 1
215 STOMA SITE DISCHARGE 1
216 SURGERY 1
217 SWELLING 1
218 SYRINGE ISSUE 1
219 TENDONITIS 1
220 THERAPY INTERRUPTED 1
221 THINKING ABNORMAL 1
222 THROMBOCYTOPENIA 1
223 THROMBOSIS 1
224 TONSILLAR DISORDER 1
225 TRANSFUSION 1
226 TRANSIENT ISCHAEMIC ATTACK 1
227 TUMOUR PAIN 1
228 UNDERDOSE 1
229 URTICARIA 1
230 VASCULITIS 1
231 VISUAL IMPAIRMENT 1
232 VULVOVAGINAL SWELLING 1
233 WHITE BLOOD CELL COUNT INCREASED 1
234 WOUND DEHISCENCE 1